Joint Transnational Call (JTC2011)

These projects were funded under E-Rare.

Factsheet (PDF)

General information
Topic: European Research Projects on Rare Diseases
Budget: 9,5 Million €
Funded projects: 13
The following parties have decided to open the third E-Rare joint transnational call (JTC 2011) for funding multilateral research projects on rare diseases:

  • The Austrian Science Fund (FWF), Austria
  • The Research Foundation Flanders (FWO), Belgium, Flanders
  • The Fund for Scientific Research (FNRS), Belgium, French-speaking community
  • The French National Research Agency (ANR), France
  • The Federal Ministry of Education and Research (BMBF), Germany
  • The General Secretariat for Research and Technology, Ministry of Education, Life Long Learning and Religious Affairs (GSRT), Greece
  • The Italian National Institute of Health (ISS), Italy
  • The Chief Scientist Office of the Ministry of Health (CSO/MOH), Israel
  • The Institute of Health Carlos III (ISCIII), Spain
  • The Scientific and Technological Research Council of Turkey (TÜBITAK), Turkey

  • CRANIRARE-2: An integrated clinical and scientific approach for craniofacial malformations
  • EDEN: Eugène Devic European Network: establishment and use of an European database and biological bank for research and treatment in acute neuromyelitis optica and related disorders 
  • EURO-CDG: A European research network for a systematic approach to CDG and related diseases
  • Euro-SCAR: Nosology and molecular diagnosis of the degenerative recessive ataxias
  • GENOMIT: Mitochondrial Disorders – Connecting Biobanks, Empowering Genetic Diagnostics and Exploring Disease Models
  • HEMO-iPS: Use of patient-specific induced pluripotent stem cells to improve diagnosisand treatment of hemophilia A
  • IPF-AE: Acute Exacerbation of Idiopathic Pulmonary Fibrosis: Mechanism and Biomarkers
  • MTMPathies2: MTM1 and MTMR2 myotubularins: biochemical activity and the regulation of membrane trafficking in health and disease
  • Rare-G: The Epidermal Growth Factor System in Rare Glomerular Disease: From Molecular Mechanisms to Therapeutics
  • SkinDev: In vitro and in vivo models of congenital rare skin diseases for molecular characterization and drug screening
  • TRANSPOSMART: An innovating platform using transposon and S/MAR for von Willebrand disease gene therapy
  • TUB-GENCODEV: Genetics of cortical gyral dysgenesis and pathophysiology of tubulin-related malformations of cortical development
  • WHIM-Thernet: WHIM syndrome: Pathological basis and development of therapeutic molecules